| Institution: | 1. Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL, USA;2. PATH, Washington, DC, USA;3. Department of Virology, Institute of Experimental Medicine, Saint Petersburg, Russia;1. Laboratory of Mycobacterial Diseases and Cellular Immunology, Center for Biologics Evaluation and Research, Silver Spring, MD 20993, United States;2. Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD 20993, United States;1. Immunization Information Systems Support Branch, Immunization Services Division, Centers for Disease Control and Prevention, Atlanta, GA, USA;2. Epidemiology and Preparedness Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA;1. Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA;2. MedImmune LLC, Mountain View, CA, USA;1. Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Institute of Epidemiology, Südufer 10, 17493 Greifswald – Insel Riems, Germany;2. Department of Epidemiology, Crisis-organization and Diagnostics, Central Veterinary Institute part of Wageningen UR, PO Box 65, 8200 AB Lelystad, Netherlands |
